Apnimed, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-27. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 42 people.
| Name | Role | Location |
|---|---|---|
| Joseph C. Avellone | Director | Cambridge, MA |
| Francois C. Beaubien | Director | Cambridge, MA |
| Isaac C. Cheng | Director | Cambridge, MA |
| Chris C. Dimitropoulos | Director | Cambridge, MA |
| Paul C. Fonteyne | Director | Cambridge, MA |
| Kevin C. Lind | Director | Cambridge, MA |
| Lawrence G. Miller | Director | Cambridge, MA |
| Gary C. Sender | Director | Cambridge, MA |
| Ramzi C. Benamar | Executive Officer | Cambridge, MA |
| Lawrence G. Miller | Executive Officer | Cambridge, MA |
| Dennis G. Molnar | Executive Officer | Cambridge, MA |
| Barry G. Wohl | Executive Officer | Cambridge, MA |
| Kevin C Lind | Director | Cambridge, MA |
| Ramzi C Benamar | Executive Officer | Cambridge, MA |
| Dennis G Molnar | Director | Cambridge, MA |
| Dennis G Molnar | Executive Officer | Cambridge, MA |
| Barry G Wohl | Executive Officer | Cambridge, MA |
| Chris C Dimitropoulos | Director | Cambridge, MA |
| Francois C Beaubien | Director | Cambridge, MA |
| Paul C Fonteyne | Director | Cambridge, MA |
| Gary C Sender | Director | Cambridge, MA |
| Lawrence G Miller | Director | Cambridge, MA |
| Lawrence G Miller | Executive Officer | Cambridge, MA |
| Isaac C Cheng | Director | Cambridge, MA |
| Joseph C Avellone | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-12-08 | D/A | $35.0M | $35.0M |
| 2025-10-01 | D/A | $35.0M | $35.0M |
| 2025-09-24 | D | $23.0M | $23.0M |
| 2025-04-24 | D | $16.5M | $16.5M |
| 2023-11-08 | D | $37.5M | — |
| 2022-12-23 | D | $79.7M | $79.7M |
| 2022-11-01 | D/A | $62.5M | $62.5M |
| 2022-05-10 | D | $62.5M | $37.5M |
| 2021-03-25 | D | $25.0M | $25.0M |
| 2020-04-07 | D | $15.0M | $15.0M |
| 2019-08-07 | D/A | $25.6M | $25.6M |
| 2019-01-10 | D/A | $25.6M | $19.6M |
| 2018-08-09 | D/A | $25.6M | $9.6M |
| 2018-07-06 | D | $25.6M | $5.1M |